Introduction
Control of tuberculosis due to Mycobacterium tuberculosis of the drug-resistant phenotype has become one of the major problems not only in the developing countries, but also in the developed countries'. Understanding of the molecular basis of resistance might help the establishment of novel rapid method for diagnosing drug-resistant M. tuberculosis strains. Rifampicin is one of the key drugs for treatment of tuberculosis. Patients who are suffering from tuberculosis caused by rifampicin-resistant strains have a poor prognosis, especialy when the rifampicin resistance is associated with resistance to other antituberculous agents2). The phenotype of resistance to rifampicin in M. tuberculosis is known to be developed to a high-level in a single step3). Mutants arise spontaneously in strains not exposed previously to the antibiotics at a rate of one mutation per 107 to 108 organisms. Resistance to rifampicin in M. and type strains of M. tuberculosis, followed by solid phase PCR product direct sequencing$) according to the strategy shown in Fig. 1 . When DNAs of these M. tuberculosis strains were analyzed by the PCR by using the strategy described above, the expected products were obtained in all cases. To facilitate direct DNA sequencing and to reduce artifacts resulting from the misincorporation of nucleotides by Taq DNA polymerase and cloning errors, one of the PCR primers was end-labeled with biotin, thus allowing the PCR products to be purified in a rapid and simple manner by using streptavidin-coated magnetic beads. After strand separation, the nucleotide sequences of the regions of our interest were obtained by the dideoxy method. Typical results obtained with the A.L.F. fluorescent auto DNA sequencer with type strain H37Rv (Fig 2, raw 1) , a rifampicin-susceptible clinically isolated strain (Fig 2, raw 2) , and two rifampicin-resistant clinical isolates (Fig 2, raw C &  D) are shown. Substitutions of nucleotides could be easily distinguished from the electrophoretic profile.
All clinically isolated rifampicin-susceptible M. tuberculosis strains and 4 type strains (H37Rv, H37Ra, Aoyama B and ATCC35416) exhibited identical nucleotide sequences. In striking contrast , 11 different mutations were found among the 44 rifampicin-resistant M. tuberculosis strains ( Table 1) . Most of them were single nucleotide substitutions. Two-amino acid substitutions (526His 527Lys-ProGln) according to 3 nucleotide substitutions was found in only one isolate. Mutations of 531Ser were present in 23 (48.9%) of the rifampicin-resistant strains (Fig. 2 row D and Table 1 ). Second dominant mutations were found on 526His (13 [27.6%], Fig. 2 row C and Table 1 ) . Three rifampicinresistant isolates had no mutations identified in the rpo B region examined in this study. None of the 17 riampicin-susceptible clinical isolates or of the 4 type strains (H37Rv , H37Ra, Aoyama B and ATCC35416) carry no mutation in the region examined in this study. * Number of corresponding E . coli position. Table 2 Correlation between mutations in the rpoB gene and rifampicin resistance of clinically isolated M. tuberculosis in three areas of Japan
From another point of view, we examined strains from 3 geographically distinct areas in Japan, Kanto, Kansai and Chugoku. No geographical clustering of mutations was found. Furthermore, the mutation frequencies of rifampicin-resistant isolates from these 3 areas were not different from each other (Table2).
Discussion
Currently, detection of drug-resistant M. tuberculosis takes at least 3 weeks even by the direct method. It takes between 6 and 8 weeks to get the results by the indirect method. Thus, treatment is prescribed empirically. Patients who fail to respond to a drug remain infectious. They may be a source of infection from patient to patient, those from patient to people who are giving the medical treatment, and from patient to a member(s) of his or her family.
Numerous efforts have been made to determine the molecular basis of resistance to antituberculous agents. Zhang et al.9 have described the relationship between deletion of a catalaseperoxidase gene and the high level of resistance to isoniazid in M. tuberculosis. Another gene which confers resistance to isoniazid at a low level has been isolated and termed inhA gene". The rpsL gene encoding the S12 protein of the ribosomal small subunit has been shown to be involved in resistance to streptomycin").
But these genes can account for only a part of the streptomycin-resistant strains. Other mutations which can account for the remaining streptomycin-resistant strains were found in the gene encoding 16S ribosomal RNAl2, 13, 14) The mode of action of rifampicin has been shown to involve interference with transcription and RNA elongation by binding of the drug to the /3 subunit of RNA polymerase. Rifampicin-resistant phenotypes arise by mutations in the key amino acids that result in conformational changes and defective binding of the drug.
In our study, 2 dominant mutations were found in 531Ser and 526His (72.3%). Substitutions of a limited number of amino acids in the rpo B gene result in rifampicin resistance of clinical isolated strains of M. tuberculosis in Japan. However, 3 rifampicin-resistant isolates (6.4%) had no identifiable mutations in the rpoB gene of our interest. Telenti et al.11) reported a similar observation. The distribution of mutations represented in this study and those reported by Telenti et al. exhibit a similar tendency regarding their positions and frequencies (Fig. 3 ). Similar observations have been for Mycobacterium leprae15). These amino acids are conserved among several bacterial species and their mutation also results in rifampicin resistance in E. coli 5'6). The mutations reported here may confer resistance to rifampicin in M. tuberculosis. However a permeability barrier to rifampicin has been identified in Mycobacterium intracellulare16) and this may be present in other non-tuberculous mycobacteria. No mutation was identified in 3 of the 47 (6.4%) rifampicin-resistant M. tuberculosis isolates. They are being repeatedly tested for resistance in our laboratory. We cannot exclude the existence of additional clusters of mutations: substitution of amino acids 687 and 146, located outside the region of rpo B we studied, has been found in E. coli. Plasmid or transposon-mediated mechanisms of resistance have not been reported for M. tuberculosis.
The relationship between rifampicin resistance and mutations in the region studied in this investigation did not differ with the geographical area.
Tuberculosis, particularly outbreaks with multi-drug-resistant M. tuberculosis, is a major problem in Japan. Direct detection of rifampicin resistance should be a powerful tool for identification of multi-drug-resistant tuberculosis, since most of those isolates are resistant to rifampicin . Our study represents a first step towards development of a rapid method for detecting drug-resistant M . tuberculosis in Japan.
